Risks of venous thromboembolism with various hormonal contraceptives.
Department of Family Medicine, University of Alberta, Edmonton, Alberta.
G Michael
GM
Allan
Sudha
S
Koppula
D000279:Administration, Cutaneous; D000293:Adolescent; D003270:Contraceptive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated / Q000009:adverse effects*; D008875:Middle Aged; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects; D012306:Risk; D054556:Venous Thromboembolism / Q000139:chemically induced*; D055815:Young Adult
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins